SphereBio
SphereBio is a biotechnology company revolutionizing cancer and autoimmune disease treatment through nanotechnology, artificial intelligence, and synthetic biology. They offer a biotech delivery platform that efficiently delivers molecules to cells, training them to recognize and kill cancer cells. This platform provides pharmaceutical companies with a novel approach for treatments tailored to individual patient's disease singularities. SphereBio utilizes bioinformatics algorithms to decode tumors and design personalized therapies, combining synthetic virology with nanotechnology for efficient delivery. Their mission is to deliver groundbreaking, personalized cancer vaccines and therapeutics, aiming for precision, personalization, and directed treatment with fewer side effects and increased efficacy, ultimately saving more lives.
SphereBio
SphereBio is a biotechnology company revolutionizing cancer and autoimmune disease treatment through nanotechnology, artificial intelligence, and synthetic biology. They offer a biotech delivery platform that efficiently delivers molecules to cells, training them to recognize and kill cancer cells. This platform provides pharmaceutical companies with a novel approach for treatments tailored to individual patient's disease singularities. SphereBio utilizes bioinformatics algorithms to decode tumors and design personalized therapies, combining synthetic virology with nanotechnology for efficient delivery. Their mission is to deliver groundbreaking, personalized cancer vaccines and therapeutics, aiming for precision, personalization, and directed treatment with fewer side effects and increased efficacy, ultimately saving more lives.